Policy shifts on peptides, plastics, and player performance

Today's news shows regulators opening doors for compounds like peptides, while science reveals microplastics are clogging arteries, and elite sports doubles down on athlete health.

1. Peptides go mainstream, but science debates

The FDA's advisory panel has cleared the way for compounding pharmacies to produce peptides previously in regulatory limbo. This reduces barriers to access for these amino acid chains, influencing their use for longevity and recovery. Expect broader availability and more consumer experimentation, even as official studies catch up.

If you're already using peptides, they'll become easier to get. If you're on the fence, expect more marketing and broader use, but remember the science is still nascent on long-term effects.

Evidence from today:

• FDA Panel Endorses Previously Unproven Peptides for Bulk Sale — An FDA advisory committee just recommended adding several unproven peptides, including some known for anti-aging and muscle growth, to the list of substances pharmacies can legally compound. This move could ease access to these non-FDA-approved amino acid chains for health providers and consumers, despite ongoing debates about efficacy and safety.
• FDA backs compounding pharmacies for four key peptides — An FDA advisory panel recommended allowing compounding pharmacies to continue making four popular peptides: AOD-9604, BPC-157, CJC-1295, and PT-141. This move bypasses a potential ban, keeping these compounds accessible through prescription. It's a win for providers and patients who rely on personalized peptide treatments.

2. Pro sports invests in recovery science

Elite sports is looking to extend careers and boost performance by integrating advanced recovery and wellness strategies. Partnerships with medical institutions mean more research into player health, which could trickle down to general fitness practices. They're investing in physical and mental longevity for athletes.

Watch for new recovery tech and methodologies to emerge from these high-performance environments. What works for pros often becomes the standard for serious amateurs a few years later.

Evidence from today:

• NBPA Teams with Cleveland Clinic for Player Wellness — The NBA Players Association (NBPA) partnered with the Cleveland Clinic, a major US healthcare system, for sports-medicine research and player wellness initiatives. This collaboration will focus on health and performance at the NBPA's high-tech performance lab in Spain. The goal is to optimize player conditioning and recovery.
• Sweat and Tonic opens massive group strength studio in Toronto — Sweat and Tonic's new 18,000-square-foot location in Toronto features what they're calling the city's first high-capacity group strength training studio. This expansion means more accessible strength training options in a premium boutique setting. It's a bet on communal fitness driving engagement and performance.

3. Microplastics are a cardiovascular threat

New research shows microplastics and nanoplastics directly cause inflammation in arteries, doubling the risk of heart attack, stroke, and death. These particles likely exert their effects by disrupting cellular function and promoting chronic immune responses. This shifts plastics from an environmental concern to a direct, acute physiological threat.

This isn't just about oceans. This is about what's in your body and what affects your heart health. It adds weight to reducing plastic exposure in daily life.

Evidence from today:

• Microplastics Found in 84% of Severe Heart Attack Patients' Arteries — A new study by Dr. Raffaele Marfella in the New England Journal of Medicine found microplastics and nanoplastics in the arteries of 84% of patients undergoing surgery for severe heart attack or stroke. These particles, specifically polyethylene and PVC, were linked to higher inflammation and a doubled risk of heart attack, stroke, or death within 34 months. This suggests everyday plastic exposure could be directly contributing to cardiovascular disease.
• Health supply chain vulnerable to climate change, war — A new Lancet comment highlights how climate change and global conflict, like the US-Israel war on Iran, expose major vulnerabilities in the healthcare supply chain. Our critical medical supplies—vaccines, drugs, diagnostics—rely heavily on fossil fuels and petrochemicals for production and distribution. This isn't just about geopolitics; it's about what happens when your local pharmacy can’t get its usual stock.

4. Policy lags public health crises

From measles outbreaks driven by vaccine hesitancy to confusing food safety communications and vulnerable supply chains, policy decisions and their implementation are failing to protect public health. The mechanisms are varied — individual decision-making, systemic negligence, and geopolitical instability — but the outcome is increased public risk and burden.

Expect more preventable disease and health crises unless there's a significant overhaul in how public health policy is crafted and communicated. Your personal health still depends on what decision-makers do, or don't do.

Evidence from today:

• US Measles Outbreak Near 30-Year High Amid Vaccine Skepticism — Measles infections in the US are hitting levels not seen in over three decades, driven by declining vaccination rates. Pediatricians in 'hot spots' like Utah are reporting terrified children and a potential loss of the country's measles elimination status. This signals a concerning public health challenge for immunity and overall community health.
• Cyclosporiasis outbreaks: bad comms make parasites worse — Recent cyclosporiasis outbreaks linked to produce have sparked criticism of government health agencies for their confusing and delayed public messaging. The Atlantic highlights how inconsistent communication escalated public concern during infection flare-ups.
• US Political Health Slogans Don't Hold Up to Science — A Nature News piece reviews political rhetoric around public health in the US, finding that many popular slogans lack scientific backing. It analyzes claims related to chronic diseases, mental health, and healthcare access. The review cautions against policies born from populist slogans rather than evidence-based interventions.
• Health supply chain vulnerable to climate change, war — A new Lancet comment highlights how climate change and global conflict, like the US-Israel war on Iran, expose major vulnerabilities in the healthcare supply chain. Our critical medical supplies—vaccines, drugs, diagnostics—rely heavily on fossil fuels and petrochemicals for production and distribution. This isn't just about geopolitics; it's about what happens when your local pharmacy can’t get its usual stock.

Also moved today

• Cycling Studios Struggle to Retain New Riders (Athletech News) — Cycling studios are struggling to keep new riders, highlighting retention issues in high-intensity fitness business models.
• Younger biological age linked to easier calorie restriction and weight loss (New Scientist) — Biological age, measured by epigenetic clocks, may predict how easily someone can lose weight through calorie restriction.
• Blood tests predict Alzheimer’s risk years before symptoms (Mindbodygreen) — New blood tests can flag Alzheimer's risk a decade early, but without treatments, this raises questions about utility.
• Self-care HIV model saves money in Africa, increases access (The Lancet Global Health) — Self-care models for HIV treatment in Africa could be cost-effective and increase access, if implemented by policymakers.
• 'Golden Girls' Home Sharing Gains Traction for Older Adults (KFF Health News) — Shared living arrangements are gaining popularity among older adults to combat rising housing costs and isolation.
• New Scientist confirms few anti-aging supplements actually work (New Scientist) — Most anti-aging supplements lack scientific backing, with only a few like NMN, creatine, and polyphenols showing real promise.
• Most neurons in mammal brains are generalists, not specialists (New Scientist) — New research suggests most brain neurons are adaptable generalists, overturning the long-held belief that they are highly specialized.
• Hilo Launches At-Home Blood Pressure Monitoring System in US (Longevity.Technology) — Hilo's new at-home blood pressure system aims to make daily monitoring easier, shifting from clinic visits to continuous data for cardiac health.
• Experts say: Test first, supplement second for personalized nutrition (Longevity.Technology) — Experts advocate for biomarker testing before supplementing, encouraging data-driven personal nutrition instead of guesswork.
• Osteoporosis Meds Need This One Thing to Really Work (Mindbodygreen) — Osteoporosis medications need to be combined with regular exercise for effective bone density improvement, especially as people age.

What I'd watch next

Keep an eye on political discourse around public health as an election year approaches; rhetoric often outpaces science. Also, watch for initial consumer reactions to newly accessible peptides as the market expands.